Corporate News

The Care Quality Commission (CQC) is the independent regulator of health and social care in England whose responsibility is to monitor, inspect and regulate services to ensure they meet fundamental standards of quality and safety.

The provision of Holter analysis in the UK is regulated by CQC under the category Diagnostic and Screening Procedures and registration is a legal requirement under the Health and Social Care Act 2008.

Globalization of products and services is here to stay but over-reliance on overseas suppliers carries inherent risk. The current UK shortages of PPE during COVID-19, are due in part to a lack of domestic manufacturing capacity and thus control.

COVID-19 has been a wake-up call on a multitude of levels but as much as we need our essential NHS and key workers, perhaps,

Ambulatory ECG or Holter monitoring is the primary diagnostic test for cardiac arrhythmia. Approximately 500,000-600,000 Holter tests are performed by the NHS annually in the UK alone.

Holter monitoring is vital in the detection of Atrial Fibrillation (the most commonly preventable cause of stroke), Palpitation investigations, Transient Loss of Consciousness investigations (responsible for 6% of all A&E attendances), Stroke of unknown cause / Post Transient Ischemic Attack (TIA) investigations.